New Tools for Predicting Capillary Leak Shock During Dengue Fever
PrediDengue
1 other identifier
interventional
342
1 country
1
Brief Summary
Evaluate the prognostic value of different methods (Osmometry / clinical-biological score) compared to the occurrence of capillary leak shock during dengue fever.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 14, 2020
CompletedFirst Submitted
Initial submission to the registry
June 5, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 14, 2023
CompletedDecember 10, 2020
December 1, 2020
2 years
June 5, 2020
December 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of a shock
The primary outcome measure will be the occurrence of a shock defined by systolic blood pressure \<90 mm Hg in adults and \<80 mm Hg in children.
2 years
Secondary Outcomes (6)
Predictive value of plasma hypo-osmolarity
2 years
Validation of the clinical-biological prognostic score
2 years
Relationship between the measurements obtained by osmolarity and capillary leakage
2 years
Evaluation of the sensitivity / specificity and predictive values of osmolarity and capillary leakage
2 years
How long before the shock these measures (osmolarity, score) allow to predict an unfavorable evolution
2 years
- +1 more secondary outcomes
Study Arms (1)
Single Arm
OTHERSingle Arm
Interventions
Interventional research protocol involving the human person category 2 at risk and minimal constraints
Eligibility Criteria
You may qualify if:
- Age\> = 5 years
- Patient / parent consent
You may not qualify if:
- Age \<5 years
- Refusal to participate
- Unsigned consent
- Coinfection by another agent
- Patient under guardianship or curatorship.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Centre Hospitalier de Cayennelead
- European Regional Development Fundcollaborator
Study Sites (1)
General Hospital of Cayenne
Cayenne, French Guiana, 97306, France
Related Publications (1)
Djossou F, Vesin G, Elenga N, Demar M, Epelboin L, Walter G, Abboud P, Le-Guen T, Rousset D, Moreau B, Mahamat A, Malvy D, Nacher M. A predictive score for hypotension in patients with confirmed dengue fever in Cayenne Hospital, French Guiana. Trans R Soc Trop Med Hyg. 2016 Dec 1;110(12):705-713. doi: 10.1093/trstmh/trx004.
PMID: 28938048BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mathieu NACHER, MD, PhD
Centre Hospitalier de Cayenne
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2020
First Posted
June 9, 2020
Study Start
May 14, 2020
Primary Completion
May 14, 2022
Study Completion
May 14, 2023
Last Updated
December 10, 2020
Record last verified: 2020-12